VX-150

N/A

Report date: 2024/01/25 20:04:27
NME

Base Information

Drug NameVX-150
Drug Alias NameVX-150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsAcute PainPainSmall Fiber Neuropathy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsItaly +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsAcute PainSmall Fiber NeuropathyOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A